Le Lézard
Classified in: Health
Subject: SVY

Global Disruptive Behavior Disorder (DBD) Treatment Market 2014-2018 & 2026 Featuring Key Players - Highland Ridge Hospital, Lakeview Health, Boston Children's Hospital & INTEGRIS Health


DUBLIN, Nov. 16, 2018 /PRNewswire/ --

The "Disruptive Behavior Disorder (DBD) Treatment Market Size, Share & Trends Analysis Report By Type (Oppositional Defiant, Conduct), By Treatment (Parenting, Individual), By Region, And Segment Forecasts, 2018 - 2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global disruptive behavior disorder treatment market size is expected to reach USD 24.0 billion by 2026 and is projected to expand at a CAGR of 4.9%

Increasing cases of substance abuse across the globe are considered to be the key factors driving the market. Drug abuse is one of the major causes for acquiring oppositional defiant and conduct disorder as it enhances the symptoms for such conditions. Rising prevalence of mental disorders among children and teenagers is leading to increased awareness regarding the associated treatments, there by augmenting the market growth.

For instance, according to the Substance Abuse and Mental Health Services Administration (SAMHSA), globally, around 3.0% of children suffer from Oppositional Defiant Disorder (ODD) and around 8.0% of children suffer from Conduct Disorder (CD) per year. In recent times, majority of the parents of children aged between 5 and 14 years have undergone workshops and trainings for the treatment of above-mentioned conditions. Several hospitals, clinics, and institutes are organizing campaigns to create awareness about the relevant treatments among parents and physicians.

For instance, the Child Mind Institute, Inc., organized a campaign named Speak Up for Kids, in May 2018, where children's mental health issues and various treatments and policies related to these disorders were discussed. Therefore, such initiatives are expected to bolster the market growth over the forecast period.

Further key findings from the study suggest:

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis
2.3 Region Wise Market Calculation
2.4 Region Based Segment Share Calculation
2.5 List of Secondary Sources (partial list)
2.6 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Increase in prevalence of disruptive behavior disorder
3.1.1.2 Rising awareness towards treatment
3.1.2 Market restraint analysis
3.1.2.1 Low funding on mental health care treatment
3.1.3 Penetration & growth prospect mapping
3.2 Disruptive Behavior Disorder Treatment Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.3 Industry Analysis - Porter's

Chapter 4 Type Estimates & Trend Analysis
4.1 Disruptive Behavior Disorder Treatment Market: Type Movement Analysis
4.2 Oppositional Defiant Disorder
4.3 Conduct Disorder
4.4 Intermittent Explosive Disorder

Chapter 5 Treatment type Estimates & Trend Analysis
5.1 Disruptive Behavior Disorder Treatment Market: Treatment Movement Analysis
5.2 Medication Management
5.3 Comprehensive Evaluation
5.4 Parenting Therapy
5.5 Group Therapy
5.6 Individual Therapy

Chapter 6 Regional Estimates & Trend Analysis, by Type And Treatment
6.1 Disruptive Behavior Disorder Treatment Market Share By Region, 2017 & 2026

Chapter 7 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/lltflw/global_disruptive?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...



News published on and distributed by: